• Globe Newswire

OMass Therapeutics appoints Birgitte Volck as Non-Executive Director

Globenewswire -

• Globe Newswire

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome

• Globe Newswire

Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm

• Globe Newswire

Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering

• Globe Newswire

Axiom Exhibiting at Outsourcing in Clinical Trials West

TORONTO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ('Axiom'), a premier provider of unified eClinical solutions and services focused on...